Processa Pharmaceuticals, Inc. Increase (Decrease) in Accrued Liabilities
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Accrued Liabilities of -$451.99 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-14
- Processa Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$412.26K, a 170.77% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$39.73K, a 138.95% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $155.65K, a 6.19% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$239.44K.
- Processa Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $600.73K, a 38.91% increase from fiscal 2024.
- Processa Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $432.46K.
- Processa Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was -$256.79K, a 205.33% decline from fiscal 2022.
- Processa Pharmaceuticals, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $243.80K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed | Increase (Decrease) in Accrued Liabilities 27 month | Increase (Decrease) in Accrued Liabilities 30 month | Increase (Decrease) in Accrued Liabilities 33 month | Increase (Decrease) in Accrued Liabilities 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$412.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$451.99K 10-Q · filed 2026-08-14 | -$296.34K derived: sum of 3 quarters · filed 2026-08-14 | -$535.78K derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2026-03-31 | -$39.73K 10-Q · filed 2026-05-07 | $115.92K derived: sum of 2 quarters · filed 2026-05-07 | -$123.52K derived: sum of 3 quarters · filed 2026-05-07 | $458.98K derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-12-31 | $155.65K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$83.79K derived: sum of 2 quarters · filed 2026-03-18 | $498.71K derived: sum of 3 quarters · filed 2026-08-14 | $600.73K 10-K · filed 2026-03-18 | ||||||||
| 2025-09-30 | -$239.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $343.06K derived: sum of 2 quarters · filed 2026-08-14 | $445.07K 10-Q · filed 2025-11-06 | $610.99K derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-06-30 | $582.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $684.51K 10-Q · filed 2026-08-14 | $850.43K derived: sum of 3 quarters · filed 2026-08-14 | $757.85K derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-03-31 | $102.02K 10-Q · filed 2026-05-07 | $267.93K derived: sum of 2 quarters · filed 2026-05-07 | $175.35K derived: sum of 3 quarters · filed 2026-05-07 | $215.13K derived: sum of 4 quarters · filed 2026-05-07 | ||||||||
| 2024-12-31 | $165.92K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $73.33K derived: sum of 2 quarters · filed 2026-03-18 | $113.11K derived: sum of 3 quarters · filed 2026-03-18 | $432.46K 10-K · filed 2026-03-18 | ||||||||
| 2024-09-30 | -$92.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$52.80K derived: sum of 2 quarters · filed 2025-11-06 | $266.54K 10-Q · filed 2025-11-06 | $210.58K derived: sum of 4 quarters · filed 2025-11-06 | ||||||||
| 2024-06-30 | $39.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $359.12K 10-Q · filed 2025-08-07 | $303.16K derived: sum of 3 quarters · filed 2025-08-07 | $193.90K derived: sum of 4 quarters · filed 2025-08-07 | ||||||||
| 2024-03-31 | $319.34K 10-Q · filed 2025-05-08 | $263.38K derived: sum of 2 quarters · filed 2025-05-08 | $154.12K derived: sum of 3 quarters · filed 2025-05-08 | $202.53K derived: sum of 4 quarters · filed 2025-05-08 | ||||||||
| 2023-12-31 | -$55.96K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$165.23K derived: sum of 2 quarters · filed 2025-03-20 | -$116.81K derived: sum of 3 quarters · filed 2025-03-20 | -$256.79K 10-K · filed 2025-03-20 | ||||||||
| 2023-09-30 | -$109.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$60.85K derived: sum of 2 quarters · filed 2024-10-30 | -$200.82K 10-Q · filed 2024-10-30 | $105.83K derived: sum of 4 quarters · filed 2024-10-30 | ||||||||
| 2023-06-30 | $48.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$91.56K 10-Q · filed 2024-08-13 | $215.09K derived: sum of 3 quarters · filed 2024-08-13 | $124.09K derived: sum of 4 quarters · filed 2024-08-13 | ||||||||
| 2023-03-31 | -$139.97K 10-Q · filed 2024-05-10 | $166.68K derived: sum of 2 quarters · filed 2024-05-10 | $75.67K derived: sum of 3 quarters · filed 2024-05-10 | $90.52K derived: sum of 4 quarters · filed 2024-05-10 | ||||||||
| 2022-12-31 | $306.65K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $215.65K derived: sum of 2 quarters · filed 2024-03-29 | $230.50K derived: sum of 3 quarters · filed 2024-03-29 | $243.80K 10-K · filed 2024-03-29 | ||||||||
| 2022-09-30 | -$91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$76.16K derived: sum of 2 quarters · filed 2023-11-13 | -$62.86K 10-Q · filed 2023-11-13 | -$251.89K derived: sum of 4 quarters · filed 2023-11-13 | ||||||||
| 2022-06-30 | $14.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $28.15K 10-Q · filed 2023-08-10 | -$160.89K derived: sum of 3 quarters · filed 2023-08-10 | -$181.34K derived: sum of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | $13.30K 10-Q · filed 2023-05-15 | -$175.73K derived: sum of 2 quarters · filed 2023-05-15 | -$196.18K derived: sum of 3 quarters · filed 2023-05-15 | -$60.97K derived: sum of 4 quarters · filed 2023-05-15 | ||||||||
| 2021-12-31 | -$189.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$209.48K derived: sum of 2 quarters · filed 2023-03-30 | -$74.27K derived: sum of 3 quarters · filed 2023-03-30 | -$65.05K 10-K · filed 2023-03-30 | -$65.41K 10-K · filed 2022-03-30 | |||||||
| 2021-09-30 | -$20.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $114.77K derived: sum of 2 quarters · filed 2022-11-08 | $123.98K 10-Q · filed 2022-11-08 | $153.98K 10-Q · filed 2021-11-12 | -$48.94K derived: sum of 4 quarters · filed 2022-11-08 | |||||||
| 2021-06-30 | $135.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $144.43K 10-Q · filed 2022-08-11 | -$28.49K derived: sum of 3 quarters · filed 2022-08-11 | $51.86K derived: sum of 4 quarters · filed 2022-08-11 | ||||||||
| 2021-03-31 | $9.22K 10-Q · filed 2022-05-12 | -$163.70K derived: sum of 2 quarters · filed 2022-05-12 | -$83.36K derived: sum of 3 quarters · filed 2022-05-12 | $397.00 derived: sum of 4 quarters · filed 2022-05-12 | ||||||||
| 2020-12-31 | -$172.92K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$92.58K derived: sum of 2 quarters · filed 2022-03-30 | -$8.82K derived: sum of 3 quarters · filed 2022-03-30 | $11.44K 10-K · filed 2022-03-30 | ||||||||
| 2020-09-30 | $80.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $164.10K derived: sum of 2 quarters · filed 2021-11-12 | $184.36K 10-Q · filed 2021-11-12 | $273.93K derived: sum of 4 quarters · filed 2021-11-12 | ||||||||
| 2020-06-30 | $83.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $104.01K 10-Q · filed 2021-08-12 | $193.58K derived: sum of 3 quarters · filed 2021-08-12 | $14.98K derived: sum of 4 quarters · filed 2021-08-12 | ||||||||
| 2020-03-31 | $20.26K 10-Q · filed 2021-05-13 | $109.83K derived: sum of 2 quarters · filed 2021-05-13 | -$68.78K derived: sum of 3 quarters · filed 2021-05-13 | $105.28K derived: sum of 4 quarters · filed 2021-05-13 | ||||||||
| 2019-12-31 | $89.57K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$89.04K derived: sum of 2 quarters · filed 2021-03-25 | $85.02K derived: sum of 3 quarters · filed 2021-03-25 | $119.94K 10-K · filed 2021-03-25 | ||||||||
| 2019-09-30 | -$178.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$4.55K derived: sum of 2 quarters · filed 2020-11-12 | $30.37K 10-Q · filed 2020-11-12 | -$233.92K derived: sum of 4 quarters · filed 2020-11-12 | ||||||||
| 2019-06-30 | $174.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $208.98K 10-Q · filed 2020-08-05 | -$55.31K derived: sum of 3 quarters · filed 2020-08-05 | $147.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||||||
| 2019-03-31 | $34.92K 10-Q · filed 2020-05-15 | -$229.37K derived: sum of 2 quarters · filed 2020-05-15 | -$27.05K derived: sum of 3 quarters · filed 2020-05-15 | -$38.77K derived: sum of 4 quarters · filed 2020-05-15 | ||||||||
| 2018-12-31 | -$264.29K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | -$61.98K derived: sum of 2 quarters · filed 2020-03-06 | -$73.69K derived: sum of 3 quarters · filed 2020-03-06 | $28.87K 10-K · filed 2020-03-06 | ||||||||
| 2018-09-30 | $202.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $190.60K derived: sum of 2 quarters · filed 2019-11-14 | $293.16K 10-Q · filed 2019-11-14 | $231.31K derived: sum of 4 quarters · filed 2019-11-14 | ||||||||
| 2018-06-30 | -$11.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $90.84K 10-Q · filed 2019-08-14 | $28.99K derived: sum of 3 quarters · filed 2019-08-14 | $127.03K derived: sum of 4 quarters · filed 2019-08-14 | ||||||||
| 2018-03-31 | $102.56K 10-Q · filed 2019-05-14 | $40.71K derived: sum of 2 quarters · filed 2019-05-14 | $138.75K derived: sum of 3 quarters · filed 2019-05-14 | $145.74K derived: sum of 4 quarters · filed 2019-05-14 | ||||||||
| 2017-12-31 | -$61.85K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-04-08 | $36.19K derived: sum of 2 quarters · filed 2019-04-08 | $43.17K derived: sum of 3 quarters · filed 2019-04-08 | -$39.83K 10-K/A · filed 2019-04-08 | ||||||||
| 2017-09-30 | $98.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $105.02K derived: sum of 2 quarters · filed 2018-11-14 | $22.02K 10-Q · filed 2018-11-14 | -$28.23K 10-Q · filed 2017-11-20 | $100.65K derived: sum of 4 quarters · filed 2018-11-14 | |||||||
| 2017-06-30 | $6.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$76.02K 10-Q · filed 2018-08-14 | -$8.19K 10-Q · filed 2017-10-04 | $2.61K derived: sum of 3 quarters · filed 2018-08-14 | $2.61K derived: sum of 4 quarters · filed 2018-08-14 | |||||||
| 2017-03-31 | -$83.00K 10-Q · filed 2018-05-21 | -$1.07K 10-Q · filed 2017-10-04 | -$4.38K derived: sum of 2 quarters · filed 2018-05-21 | -$4.37K derived: sum of 3 quarters · filed 2018-05-21 | -$6.37K derived: sum of 4 quarters · filed 2018-05-21 | |||||||
| 2016-12-31 | $78.63K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-16 | $78.63K derived: sum of 2 quarters · filed 2018-04-16 | $76.63K derived: sum of 3 quarters · filed 2018-04-16 | $75.79K 10-K · filed 2018-04-16 | $686.00 10-K · filed 2017-09-25 | |||||||
| 2016-09-30 | $1.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | -$2.00K derived: sum of 2 quarters · filed 2017-11-20 | -$2.84K 10-Q · filed 2017-11-20 | -$12.02K derived: sum of 4 quarters · filed 2017-11-20 | ||||||||
| 2016-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | -$2.84K 10-Q · filed 2017-10-04 | -$12.02K derived: sum of 3 quarters · filed 2017-10-04 | -$4.25K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2016-03-31 | -$840.00 10-Q · filed 2017-10-04 | -$10.02K derived: sum of 2 quarters · filed 2017-10-04 | -$2.25K derived: sum of 3 quarters · filed 2017-10-04 | -$18.52K derived: sum of 4 quarters · filed 2017-10-04 | ||||||||
| 2015-12-31 | -$9.18K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | -$1.41K derived: sum of 2 quarters · filed 2017-09-25 | -$17.68K derived: sum of 3 quarters · filed 2017-09-25 | -$41.77K 10-K · filed 2017-09-25 | ||||||||
| 2015-09-30 | $7.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | -$8.50K derived: sum of 2 quarters · filed 2017-09-08 | -$32.59K 10-Q · filed 2017-09-08 | -$36.59K 10-Q · filed 2015-12-01 | -$59.42K derived: sum of 4 quarters · filed 2017-09-08 | |||||||
| 2015-06-30 | -$16.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | -$40.37K 10-Q · filed 2017-08-30 | -$54.45K 10-Q · filed 2015-08-19 | -$67.19K derived: sum of 3 quarters · filed 2017-08-30 | -$153.49K derived: sum of 4 quarters · filed 2017-08-30 | |||||||
| 2015-03-31 | -$24.09K 10-Q · filed 2017-08-07 | -$35.36K 10-Q · filed 2015-05-15 | -$50.92K derived: sum of 2 quarters · filed 2017-08-07 | -$137.22K derived: sum of 3 quarters · filed 2017-08-07 | -$191.12K derived: sum of 4 quarters · filed 2017-08-07 | |||||||
| 2014-12-31 | -$26.83K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | -$113.13K derived: sum of 2 quarters · filed 2017-06-19 | -$167.03K derived: sum of 3 quarters · filed 2017-06-19 | -$311.02K 10-K · filed 2017-06-19 | -$331.94K 10-K · filed 2015-04-14 | |||||||
| 2014-09-30 | -$86.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | -$140.20K derived: sum of 2 quarters · filed 2015-12-01 | -$284.20K 10-Q · filed 2015-12-01 | -$277.82K 10-Q · filed 2014-11-13 | -$241.50K derived: sum of 4 quarters · filed 2015-12-01 | |||||||
| 2014-06-30 | -$53.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$197.90K 10-Q · filed 2015-08-19 | -$199.46K 10-Q · filed 2014-08-19 | -$155.21K derived: sum of 3 quarters · filed 2015-08-19 | -$131.63K derived: sum of 4 quarters · filed 2015-08-19 | |||||||
| 2014-03-31 | -$144.00K 10-Q · filed 2015-05-15 | -$145.16K 10-Q · filed 2014-05-14 | -$101.30K derived: sum of 2 quarters · filed 2015-05-15 | -$77.72K derived: sum of 3 quarters · filed 2015-05-15 | -$154.53K derived: sum of 4 quarters · filed 2015-05-15 | -$73.84K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $42.69K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $66.27K derived: sum of 2 quarters · filed 2015-04-14 | -$10.53K derived: sum of 3 quarters · filed 2015-04-14 | $6.09K 10-K · filed 2015-04-14 | $69.40K 10-K · filed 2014-03-27 | |||||||
| 2013-09-30 | $23.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$53.22K derived: sum of 2 quarters · filed 2014-11-13 | -$36.60K 10-Q · filed 2014-11-13 | -$36.53K 10-Q · filed 2013-11-08 | -$11.28K derived: sum of 4 quarters · filed 2014-11-13 | $26.78K 10-Q · filed 2013-11-08 | ||||||
| 2013-06-30 | -$76.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | -$60.18K 10-Q · filed 2014-08-19 | -$60.08K 10-Q/A · filed 2013-09-06 | -$34.86K derived: sum of 3 quarters · filed 2014-08-19 | -$17.95K derived: sum of 4 quarters · filed 2014-08-19 | $3.23K 10-Q/A · filed 2013-09-06 | ||||||
| 2013-03-31 | $16.62K 10-Q · filed 2014-05-14 | $41.95K derived: sum of 2 quarters · filed 2014-05-14 | $58.85K derived: sum of 3 quarters · filed 2014-05-14 | |||||||||
| 2012-12-31 | $25.33K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $42.23K derived: sum of 2 quarters · filed 2014-03-27 | $43.31K 10-K · filed 2014-03-27 | |||||||||
| 2012-09-30 | $16.91K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-08 | $17.98K 10-Q · filed 2013-11-08 | ||||||||||
| 2012-06-30 | $1.08K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |